Document is current
Any future updates will be listed below
-
Authors
Van Nostrand, Eric L.
Pratt, Gabriel A.
Yee, Brian A.
Wheeler, Emily C.
Blue, Steven M.
Mueller, Jasmine
Park, Samuel S.
Garcia, Keri E.
Gelboin-Burkhart, Chelsea
Nguyen, Thai B.
Rabano, Ines
Stanton, Rebecca
Sundararaman, Balaji
Wang, Ruth
Fu, Xiang-Dong
Graveley, Brenton R.
Yeo, Gene W.
-
Funding
Funding for this research was provided by:
National Human Genome Research Institute (U54HG007005, U41HG009889, U41HG009889, HG009530)
National Human Genome Research Institute (U54HG007005)
Damon Runyon Cancer Research Foundation (DRG-2172-13)
- License Information
-
More Information
Article History
Received: 14 October 2019
Accepted: 3 March 2020
First Online: 6 April 2020
Ethics approval and consent to participate
: Not applicable
: Not applicable
: ELVN is co-founder, member of the Board of Directors, on the SAB, equity holder, and paid consultant for Eclipse BioInnovations. GWY is co-founder, member of the Board of Directors, on the SAB, equity holder, and paid consultant for Locana and Eclipse BioInnovations. GWY is a visiting professor at the National University of Singapore. ELVN's and GWY's interests have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. The other authors declare that they have no competing interests.
